Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ANTX
- Company AN2 Therapeutics, Inc.
- Price $5.15
- Changes Percentage -1.44
- Change -0.075
- Day Low $4.96
- Day High $5.49
- Year High $7.19
- Year Low $1
- Market Cap $176,119,037
- Price Avg 50 EMA (D) $5.46
- Price Avg 200 EMA (D) $3.63
- Exchange NASDAQ
- Volume 258,933
- Average Volume 277,095
- Open $5.13
- Previous Close $5.22
- EPS -1.1
- PE -4.45
- Earnings Announcement 2026-11-05 12:00:00
- Shares Outstanding $36,016,163
Company brief: AN2 THERAPEUTICS, INC. (ANTX )
- Healthcare
- Biotechnology
- Mr. Eric E. Easom
- https://www.an2therapeutics.com
- US
- N/A
- 03-25-2022
- US0373261058
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menlo Park, California.
